Shares of Affirm Holdings, Inc. (NASDAQ:AFRM – Get Free Report) have received an average rating of “Hold” from the twenty-one research firms that are covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $35.53.
A number of research analysts have recently commented on the stock. Mizuho reissued an “outperform” rating and issued a $65.00 target price on shares of Affirm in a report on Tuesday, August 27th. Susquehanna initiated coverage on shares of Affirm in a research note on Friday, September 20th. They set a “positive” rating and a $52.00 target price on the stock. Royal Bank of Canada increased their price target on Affirm from $43.00 to $46.00 and gave the company a “sector perform” rating in a research note on Thursday, August 29th. Wedbush increased their target price on Affirm from $20.00 to $25.00 and gave the company an “underperform” rating in a research report on Thursday, August 29th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $42.00 target price on shares of Affirm in a research report on Monday, June 24th.
View Our Latest Research Report on Affirm
Insider Activity
Institutional Investors Weigh In On Affirm
Several institutional investors have recently bought and sold shares of AFRM. Vanguard Group Inc. boosted its holdings in Affirm by 6.8% during the 1st quarter. Vanguard Group Inc. now owns 20,823,803 shares of the company’s stock worth $775,895,000 after acquiring an additional 1,316,901 shares during the last quarter. Capital World Investors boosted its holdings in Affirm by 0.4% during the first quarter. Capital World Investors now owns 19,079,071 shares of the company’s stock worth $710,886,000 after purchasing an additional 77,050 shares during the last quarter. Baillie Gifford & Co. grew its position in Affirm by 4.2% in the 1st quarter. Baillie Gifford & Co. now owns 18,732,407 shares of the company’s stock worth $697,969,000 after purchasing an additional 749,368 shares in the last quarter. Dragoneer Investment Group LLC purchased a new stake in shares of Affirm during the second quarter valued at approximately $45,219,000. Finally, Norges Bank purchased a new stake in shares of Affirm during the 4th quarter valued at $67,310,000. Institutional investors own 69.29% of the company’s stock.
Affirm Stock Down 5.7 %
Shares of NASDAQ AFRM opened at $38.48 on Wednesday. The company has a debt-to-equity ratio of 2.41, a quick ratio of 13.07 and a current ratio of 13.07. The stock has a market capitalization of $11.90 billion, a P/E ratio of -17.26 and a beta of 3.51. The stock’s fifty day moving average is $34.56 and its 200 day moving average is $32.96. Affirm has a 52 week low of $15.97 and a 52 week high of $52.48.
Affirm (NASDAQ:AFRM – Get Free Report) last issued its earnings results on Wednesday, August 28th. The company reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.45) by $0.31. Affirm had a negative return on equity of 15.55% and a negative net margin of 22.29%. The firm had revenue of $659.19 million for the quarter, compared to the consensus estimate of $599.50 million. Sell-side analysts forecast that Affirm will post -0.82 earnings per share for the current fiscal year.
Affirm Company Profile
Affirm Holdings, Inc operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months.
Recommended Stories
- Five stocks we like better than Affirm
- Why Are Stock Sectors Important to Successful Investing?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Effectively Use the MarketBeat Ratings Screener
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Affirm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affirm and related companies with MarketBeat.com's FREE daily email newsletter.